These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 9224313
1. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer. Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C. J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313 [Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report. Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T. Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990 [Abstract] [Full Text] [Related]
4. Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892). Dreicer R, Propert KJ, Roth BJ, Einhorn LH, Loehrer PJ. Cancer; 1997 Jan 01; 79(1):110-4. PubMed ID: 8988734 [Abstract] [Full Text] [Related]
5. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF. Urology; 2007 Feb 01; 69(2):255-9. PubMed ID: 17320659 [Abstract] [Full Text] [Related]
6. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW. Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121 [Abstract] [Full Text] [Related]
7. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ, Meyers FJ, Houston J, Lauder I. Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [Abstract] [Full Text] [Related]
8. [Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma]. Hattori Y, Takizawa A, Kishida T, Kakizoe M, Fujikawa N, Teranishi J, Kondo K, Saito K, Noguchi K, Nakaigawa N, Kubota Y. Gan To Kagaku Ryoho; 2007 May 15; 34(5):739-43. PubMed ID: 17496448 [Abstract] [Full Text] [Related]
9. Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies. Tu SM, Hossan E, Amato R, Kilbourn R, Logothetis CJ. J Urol; 1995 Nov 15; 154(5):1719-22. PubMed ID: 7563331 [Abstract] [Full Text] [Related]
10. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma. Hsu CH, Chen J, Wu CY, Cheng AL, Pu YS. Anticancer Res; 2001 Nov 15; 21(1B):711-5. PubMed ID: 11299831 [Abstract] [Full Text] [Related]
11. Progress in the chemotherapy of metastatic cancer of the urinary tract. Raghavan D. Cancer; 2003 Apr 15; 97(8 Suppl):2050-5. PubMed ID: 12673696 [Abstract] [Full Text] [Related]
12. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma. Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS. J Urol; 2007 Jan 15; 177(1):84-9; discussion 89. PubMed ID: 17162009 [Abstract] [Full Text] [Related]
13. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. J Urol; 1998 Nov 15; 160(5):1770-4. PubMed ID: 9783949 [Abstract] [Full Text] [Related]
14. Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens. Joung JY, Kwon WA, Cho IC, Kim EK, Park S, Yoon H, Seo HK, Chung J, Park WS, Lee KH. Int J Urol; 2011 May 15; 18(5):350-7. PubMed ID: 21355894 [Abstract] [Full Text] [Related]
15. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer]. Sella A, Flex D, Gafni D, Rabinovitz O, Sulkes A, Baniel J. Harefuah; 1999 Feb 15; 136(4):268-71, 340, 339. PubMed ID: 10914214 [Abstract] [Full Text] [Related]
16. M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen. Igawa M, Kadena H, Ueda M, Usui T. Cancer Chemother Pharmacol; 1994 Feb 15; 35 Suppl():S1-4. PubMed ID: 7527732 [Abstract] [Full Text] [Related]
17. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity]. Rassweiler J, Rüther U, Bäuerle K, Bub P, Jipp P, Eisenberger F. Urologe A; 1989 Jan 15; 28(1):25-30. PubMed ID: 2922897 [Abstract] [Full Text] [Related]
18. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules. Bajorin DF, McCaffrey JA, Dodd PM, Hilton S, Mazumdar M, Kelly WK, Herr H, Scher HI, Icasiano E, Higgins G. Cancer; 2000 Apr 01; 88(7):1671-8. PubMed ID: 10738226 [Abstract] [Full Text] [Related]
19. Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity. Lin CC, Hsu CH, Huang CY, Cheng AL, Chen J, Vogelzang NJ, Pu YS. Cancer; 2006 Mar 15; 106(6):1269-75. PubMed ID: 16470604 [Abstract] [Full Text] [Related]
20. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer]. Hashimura T, Okumura K, Akao T, Nakagawa T. Hinyokika Kiyo; 1991 Jul 15; 37(7):685-8. PubMed ID: 1927767 [Abstract] [Full Text] [Related] Page: [Next] [New Search]